Antibiotic Discovery: Where Have We Come from, Where Do We Go?
Given the increase in antibiotic-resistant bacteria, alongside the alarmingly low rate of newly approved antibiotics for clinical usage, we are on the verge of not having effective treatments for many common infectious diseases. Historically, antibiotic discovery has been crucial in outpacing resist...
Main Authors: | Bernardo Ribeiro da Cunha, Luís P. Fonseca, Cecília R. C. Calado |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/8/2/45 |
Similar Items
-
Biomarkers of endometriosis: How far have we come and where are we going?
by: Vid Janša, et al.
Published: (2021-06-01) -
Employee support: Where have we come from, and where are we going?
by: Noreen Tehrani, et al.
Published: (2023-02-01) -
Managing sarcoma: where have we come from and where are we going?
by: Jenna S. Bleloch, et al.
Published: (2017-10-01) -
Natural Products and Synthetic Biology: Where We Are and Where We Need To Go
by: Sylvia Kunakom, et al.
Published: (2019-06-01) -
Dermatology: Where Are We Coming from and Where Are We Going To?
by: Peter van de Kerkhof
Published: (2014-10-01)